This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Frohlich, E. D. Articles by Messerli, F. H. Search for Related Content PubMed Articles by Frohlich, E. D. Articles by Messerli, F. H. Social Bookmarking                         What's this?

Investigative Concerns in Demonstrating Reduced Risk from Reversing Left Ventricular Hypertrophy

Alton Ochsner Medical Foundation, New Orleans, Louisiana

Dagnovar Aristizabal

Alton Ochsner Medical Foundation, New Orleans, Louisiana

Federico Soria

Alton Ochsner Medical Foundation, New Orleans, Louisiana

Franz H. Messerli

Alton Ochsner Medical Foundation, New Orleans, Louisiana

Background: To demonstrate reduced risk from reversing left ventricular hypertrophy (LVH) in hypertension, one must show that it is independent of blood pressure reduction.

Methods and Results: A feasibility study was conducted with 15 patients. The study employed 48-hour Holter recording, exercise treadmill (for ST-segment changes) and, as nec essary, thallium scintigraphy and coronary angiography. All patients were treated for 3 months with quinapril (10 mg) and demonstrated decreased mean arterial pressure (125 ± 3.1 vs 103 ± 1.9 mmHg; P < .01) and left ventricular mass index (125 ± 6.4 vs 104 ± 4.9; P < .02) with preserved left ventricular function. There were no significant changes in these patients with moderate LVH in the incidence of arrhythmias; however, 4 of the 15 patients developed ST-segment changes prior to LVH reversal, and these changes did not recur in 3 patients following reversal of LVH or when pressure was allowed to rise.

Conclusions: Ischemic changes, rather than development of arrhythmias, may be of greater value in demonstrating risk reduction with LVH reversal. Nloreover, these preliminary data suggest pitfalls in demonstrating risk reduction after LVH reversal, indicating that more sen sitive and adequate techniques are necessary to show risk reduction from LVH.

Key Words: essential hypertension • left ventricular hypertrophy • risk from LVH • holter recording • thallium scintigraphy • treadmill testing • LVH reversal • quinapril.

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 1, No. 1, 17-22 (1996)
DOI: 10.1177/107424849600100104


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?